mfresearch ๐Ÿ”’ Show amounts

HDFC Multi Cap Fund - Direct Plan - Growth Option

code 149368 Multi Cap Fund direct plan ยท growth NAVs 2021-12-10 to 2026-11-09

Benchmark: NIFTY 500 MULTICAP 50:25:25 official TRI declared: AMFI Fund Performance (Fund-Performance-30-Sep-2026--2031 (2).xlsx), as of 2026-09-30 Compare with:

Growth of โ‚น10,000 vs benchmark

From 2021-12-10, common dates. Scroll or drag to zoom.

Drawdown

Rolling 3-year CAGR

Returns

periodfundfund*benchmark*fund โˆ’ benchmark*from โ†’ to
1M5.56% -5.64%-5.78% 0.14% 2026-10-09 โ†’ 2026-11-09
3M-2.34% -3.24%-2.81% -0.44% 2026-08-07 โ†’ 2026-11-09
6M1.35% 6.21%9.00% -2.79% 2026-05-08 โ†’ 2026-11-09
1Y-2.15% -2.78%0.55% -3.33% 2025-11-07 โ†’ 2026-11-09
3Y11.68% 10.51%10.97% -0.46% 2023-11-09 โ†’ 2026-11-09
5Y- -- -
7Y- -- -
10Y- -- -
since inception14.82% 14.17%10.97% 3.20% 2021-12-10 โ†’ 2026-11-09

Absolute under 1 year, CAGR from 1 year. * Common dates only.

Calendar years

year2022202320242025
fund11.30%41.93%22.21%3.34%
benchmark2.84%33.74%19.34%5.29%

Rolling returns

lengthperiodsaveragemedianworstbest% positive% beating benchmark
1 year93320.17%13.48% -6.51%54.49%86% 66%
3 years44420.73%21.20% 10.51%30.00%100% 84%

Risk and risk-adjusted return

3 years
2023-11 โ€“ 2026-10
CAGR10.26%
volatility16.58%
max drawdown-20.20%
downside deviation11.32%
Sharpe ratio0.32
Sortino ratio0.46
Calmar ratio0.51
alpha (annualised)-
beta-
Rยฒ-
tracking error-
information ratio-
up / down capture-
Treynor ratio-
36 months: benchmark lacks some months of the window: no relative metrics

Category: Multi Cap Fund

Overall โ˜…โ˜†โ˜†โ˜†โ˜† (3y โ˜…โ˜†โ˜†โ˜†โ˜† ยท 5y - ยท 10y -) ยท as of 2026-10 ยท 58 months of history

percentile rank (1 = best)3 years
of 23 funds
return91st
volatility60th
Sharpe91st
Sortino91st
worst fall73rd
risk-adjusted return (MRAR)91st

View category โ†’

Ratings: Morningstar method. Differences: risk-free rate: RBI 91-day T-bill (Morningstar uses FBIL MIBOR Overnight for rupee funds); peer groups: SEBI-category groups (D13), not Morningstar Categories; no analyst rating suspensions.

Add to comparison โ†’